{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T11:20:35Z","timestamp":1792063235013,"version":"4.4.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2008,3,1]],"date-time":"2008-03-01T00:00:00Z","timestamp":1204329600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pathol. Oncol. Res."],"published-print":{"date-parts":[[2008,3]]},"DOI":"10.1007\/s12253-008-9000-9","type":"journal-article","created":{"date-parts":[[2009,1,9]],"date-time":"2009-01-09T16:52:36Z","timestamp":1231519956000},"page":"23-30","source":"Crossref","is-referenced-by-count":20,"title":["p53 and BCL-2 as Prognostic Markers in Endometrial Carcinoma"],"prefix":"10.1007","volume":"14","author":[{"given":"M\u00e1rcia L. M.","family":"Appel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria I.","family":"Edelweiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Fleck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis F.","family":"Rivero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Waldemar A.","family":"Rivoire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heleusa I.","family":"M\u00f4nego","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo","family":"dos Reis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,4,9]]},"reference":[{"key":"9000_CR1","unstructured":"Instituto Nacional do C\u00e2ncer. (2006) Estimativas da Incid\u00eancia e mortalidade por c\u00e2ncer no Brasil. 2003. http:\/\/www.inca.gov.br . Accessed May 2"},{"key":"9000_CR2","first-page":"407","volume-title":"Practical gynecologic oncology","author":"NF Hacker","year":"2000","unstructured":"Hacker NF (2000) Uterine cancer. In: Berek JS and Hacker NF (eds) Practical gynecologic oncology, 3rd ed. Lippincott Williams & Wilkins, Philadelphia, pp 407\u2013456","edition":"3"},{"key":"9000_CR3","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1093\/jnci\/60.6.1209","volume":"60","author":"LM Axtell","year":"1978","unstructured":"Axtell LM, Myers MH (1978) Contrasts in survival of black and white cancer patients. J Natl Cancer Inst 60:1209\u20131215","journal-title":"J Natl Cancer Inst"},{"key":"9000_CR4","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/canjclin.50.1.7","volume":"50","author":"RT Greenlee","year":"2000","unstructured":"Greenlee RT, Murray T, Bolden S, Wingo PA (2000) Cancer statistics, 2000. CA Cancer J Clin 50:7\u201333","journal-title":"CA Cancer J Clin"},{"key":"9000_CR5","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1067\/mob.2000.107328","volume":"182","author":"A Mariani","year":"2000","unstructured":"Mariani A, Sebo TJ, Katzmann JA, Keeney GL, Roche PC, Lesnick TG, Podratz KC (2000) Pretreatment assessment of prognostic indicators in endometrial cancer. Am J Obstet Gynecol 182:1535\u20131544","journal-title":"Am J Obstet Gynecol"},{"key":"9000_CR6","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1067\/mob.2002.123203","volume":"187","author":"T Ohkouchi","year":"2002","unstructured":"Ohkouchi T, Sakuragi N, Watari H, Nomura E, Todo Y, Yamada H, Fujimoto S (2002) Prognostic significance of Bcl-2, p53 overexpression, and lymph node metastasis in surgically staged endometrial carcinoma. Am J Obstet Gynecol 187:353\u2013359","journal-title":"Am J Obstet Gynecol"},{"key":"9000_CR7","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1006\/gyno.1996.0133","volume":"61","author":"JP Geisler","year":"1996","unstructured":"Geisler JP, Wiemann MD, Zhou Z, Miller GA, Geisler HE (1996) p53 as a prognostic indicator in endometrial cancer. Gynecol Oncol 61:245\u2013248","journal-title":"Gynecol Oncol"},{"key":"9000_CR8","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1006\/gyno.1999.5482","volume":"74","author":"JP Geisler","year":"1999","unstructured":"Geisler JP, Geisler HE, Wiemann MD, Zhou Z, Miller GA, Crabtree W (1999) p53 expression as a prognostic indicator of 5-year survival in endometrial cancer. Gynecol Oncol 74:468\u2013471","journal-title":"Gynecol Oncol"},{"key":"9000_CR9","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1006\/gyno.1998.5192","volume":"71","author":"JP Geisler","year":"1998","unstructured":"Geisler JP, Geisler HE, Wiemann MC, Zhou Z, Miller GA, Crabtree W (1998) Lack of bcl-2 persistence: an independent prognostic indicator of poor prognosis in endometrial carcinoma. Gynecol Oncol 71:305\u2013307","journal-title":"Gynecol Oncol"},{"key":"9000_CR10","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/(SICI)1097-0215(19980417)79:2<153::AID-IJC10>3.0.CO;2-B","volume":"79","author":"N Sakuragi","year":"1998","unstructured":"Sakuragi N, Ohkouchi T, Hareyama H, Ikeda K, Watari H, Fujimoto T, Kuwabara M, Yamamoto R, Sagawa T, Fujino T, Fujimoto S (1998) Bcl-2 expression and prognosis of patients with endometrial carcinoma. Int J Cancer 79:153\u2013158","journal-title":"Int J Cancer"},{"key":"9000_CR11","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1159\/000227223","volume":"50","author":"H Nishioka","year":"1993","unstructured":"Nishioka H, Hiasa Y, Hayashi I, Kitahori Y, Konishi N, Sugimura M (1993) Immunohistochemical detection of p53 oncoprotein in human oral squamous cell carcinomas and leukoplasias: comparison with proliferating cell nuclear antigen staining and correlation with clinicopathological findings. Oncology 50:426\u2013429","journal-title":"Oncology"},{"key":"9000_CR12","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/modpathol.3880062","volume":"13","author":"S Kounelis","year":"2000","unstructured":"Kounelis S, Kapranos N, Kouri E, Coppola D, Papadaki H, Jones M (2000) Immunohistochemical profile of endometrial adenocarcinoma: a study of 61 cases and review of the literature. Mod Pathol 13:379\u2013388","journal-title":"Mod Pathol"},{"key":"9000_CR13","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1016\/S0002-9378(96)70036-4","volume":"175","author":"MF Kohler","year":"1996","unstructured":"Kohler MF, Carney P, Dodge R, Soper J, Clarke-Pearson DL, Marks JR, Berchuck A (1996) p53 overexpression in advanced-stage endometrial adenocarcinoma. Am J Obstet Gynecol 175:1246\u20131252","journal-title":"Am J Obstet Gynecol"},{"key":"9000_CR14","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1006\/gyno.2000.5744","volume":"77","author":"HM Morsi","year":"2000","unstructured":"Morsi HM, Leers MP, Radespiel-Tr\u00f6ger M, Bj\u00f6rklund V, Kabarity HE, Nap M, J\u00e4ger W (2000) Apoptosis, bcl-2 expression, and proliferation in benign and malignant endometrial epithelium: an approach using multiparameter flow cytometry. Gynecol Oncol 77:11\u201317","journal-title":"Gynecol Oncol"},{"key":"9000_CR15","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1159\/000012094","volume":"58","author":"M Marone","year":"2000","unstructured":"Marone M, Ferrandina G, Macchia G, Mozzetti S (2000) Bcl-2, Bax, Bcl-xl and Bcl-xs expression in neoplastic and normal endometrium. Oncology 58:161\u2013168","journal-title":"Oncology"},{"key":"9000_CR16","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S0046-8177(98)90060-0","volume":"29","author":"D Coppola","year":"1998","unstructured":"Coppola D, Fu L, Nicosia SV, Kounelis S, Jones M (1998) Prognostic significance of p53, bcl-2, vimentin, and S100 protein-positive Langerhans cells in endometrial carcinoma. Human Pathol 29:455\u2013462","journal-title":"Human Pathol"},{"key":"9000_CR17","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1097\/00004347-199607000-00003","volume":"15","author":"N Yamauchi","year":"1996","unstructured":"Yamauchi N, Sakamoto A, Uozaki H, Iihara K, Machinami R (1996) Immunohistochemical analysis of endometrial adenocarcinoma for bcl-2 and p53 in relation to expression of sex steroid receptor and proliferative activity. Int J Gynecol Pathol 15:202\u2013208","journal-title":"Int J Gynecol Pathol"},{"key":"9000_CR18","first-page":"728","volume":"10","author":"M Taskin","year":"1997","unstructured":"Taskin M, Lallas TA, Barber HR, Shevchuk MM (1997) bcl-2 and p53 endometrial adenocarcinoma. Mod Pathol 10:728\u2013734","journal-title":"Mod Pathol"},{"key":"9000_CR19","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/BF01372546","volume":"123","author":"M Saegusa","year":"1997","unstructured":"Saegusa M, Okayasu I (1997) Bcl-2 is closely correlated with favorable prognostic factors and inversely associated with p53 protein accumulation in endometrial carcinomas: immunohistochemical and polymerase chain reaction\/loss of heterozygosity findings. J Cancer Res Clin Oncol 123:429\u2013434","journal-title":"J Cancer Res Clin Oncol"},{"key":"9000_CR20","unstructured":"College of American Pathologists (2006) http:\/\/www.cap.org . Home>reference and Publications> Cancer Protocols and Checklists. Accessed 22 May"},{"key":"9000_CR21","first-page":"3689","volume":"18","author":"A Giatromanolaki","year":"1998","unstructured":"Giatromanolaki A, Sivridis E, Koukourakis MI, Harris AL, Gatter KC (1998) Bcl-2 and p53 expression in stage I endometrial carcinoma. Anticancer Res 18:3689\u20133694","journal-title":"Anticancer Res"},{"key":"9000_CR22","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/bjc.1998.128","volume":"77","author":"HJ Slooten van","year":"1998","unstructured":"van Slooten HJ, van der Vijver MJ, van der Velde CJH, van Dierendonck JH (1998) Loss of Bcl-2 in invasive breast cancer is associated with high rates of cell death, but also with increased proliferative activity. Br J Cancer 77:789\u2013796","journal-title":"Br J Cancer"},{"key":"9000_CR23","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.bbamcr.2003.10.014","volume":"1644","author":"N Bonneefoy-Berard","year":"2004","unstructured":"Bonneefoy-Berard N, Aouacheria A, Verschelde C, Quemeneur L, Mar\u00e7ais A, Marvel J (2004) Control of proliferation by Bcl-2 family members. Biochim Biophys Acta 1644:159\u2013168","journal-title":"Biochim Biophys Acta"},{"key":"9000_CR24","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1006\/gyno.1996.0119","volume":"61","author":"J Boyd","year":"1996","unstructured":"Boyd J (1996) Molecular biology in the clinicopathologic assessment of endometrial carcinoma subtypes\u2014editorial. Gynecol Oncol 61:163\u2013165","journal-title":"Gynecol Oncol"},{"key":"9000_CR25","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1016\/0046-8177(95)90203-1","volume":"26","author":"RA Ambros","year":"1995","unstructured":"Ambros RA, Sherman ME, Zahm CM, Bitterman P, Kurman RJ (1995) Endometrial intraepithelial carcinoma: a distinctive lesion specifically associated with tumors displaying serous differentiation. Hum Pathol 26:1260\u20131267","journal-title":"Hum Pathol"},{"key":"9000_CR26","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1016\/0046-8177(95)90204-X","volume":"26","author":"ME Sherman","year":"1995","unstructured":"Sherman ME, Bur ME, Kurman RJ (1995) p53 in endometrial cancer and its putative precursors: evidence for diverse pathways of tumorigenesis. Hum Pathol 26:1268\u20131274","journal-title":"Hum Pathol"},{"key":"9000_CR27","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1097\/00000478-199504000-00003","volume":"19","author":"GW Spiegel","year":"1995","unstructured":"Spiegel GW (1995) Endometrial carcinoma in situ in postmenopausal women. Am J Surg Pathol 19:417\u2013432","journal-title":"Am J Surg Pathol"},{"key":"9000_CR28","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1046\/j.1365-2559.1998.00560.x","volume":"33","author":"JL Burton","year":"1998","unstructured":"Burton JL, Wells M (1998) Recent advances in the histopathology and molecular pathology of carcinoma of the endometrium\u2014review. Histopathology 33:297\u2013303","journal-title":"Histopathology"},{"key":"9000_CR29","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1006\/gyno.2001.6429","volume":"83","author":"N Sakuragi","year":"2001","unstructured":"Sakuragi N, Hirai A, Tada M, Yamada H, Yamamoto R, Fujimoto S, et al (2001) Dominant-negative mutation of p53 tumor suppressor gene in endometrial carcinoma. Gynecol Oncol 83:485\u2013490","journal-title":"Gynecol Oncol"},{"key":"9000_CR30","first-page":"643","volume":"81","author":"MF Kohler","year":"1993","unstructured":"Kohler MF, Kerns BJ, Humprey PA, Marks JR, Bast RC, Berchuck A (1993) Mutation and overexpression of p53 in early-stage epithelial ovarian cancer. Obstet Gynecol 81:643\u2013650","journal-title":"Obstet Gynecol"},{"key":"9000_CR31","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1038\/bjc.1996.401","volume":"74","author":"R Soong","year":"1996","unstructured":"Soong R, Knowles S, Williams KE, Hammond IG, Wysocki SJ, Iacopetta BJ (1996) Overexpression of p53 protein is an independent prognostic indicator in human endometrial carcinoma. Br J Cancer 74:562\u2013567","journal-title":"Br J Cancer"},{"key":"9000_CR32","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.ygyno.2003.12.038","volume":"93","author":"S Oreskovic","year":"2004","unstructured":"Oreskovic S, Babic D, Kalafatic D, Barisic D, Beketic-Oreskovic LA (2004) Significance of immunohistochemical determination of steroid receptors, cell proliferation factor Ki-67 and protein p53 in endometrial carcinoma. Gynecol Oncol 93:34\u201340","journal-title":"Gynecol Oncol"},{"key":"9000_CR33","first-page":"177","volume":"150","author":"H Tashiro","year":"1997","unstructured":"Tashiro H, Isacson C, Levine R, Kurman RJ, Cho KR, Hedrick L (1997) p53 gene mutations are common in uterine serous carcinoma and occur early in their pathogenesis. Am J Pathol 150:177\u2013185","journal-title":"Am J Pathol"},{"key":"9000_CR34","first-page":"1799","volume":"9","author":"T Miyashita","year":"1994","unstructured":"Miyashita T, Krajewski S, Krajewska M, Wang HG, Lin HK, Liebermann DA, Hoffman B, Reed JC (1994) Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene 9:1799\u20131805","journal-title":"Oncogene"},{"key":"9000_CR35","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1590\/S1516-31802003000400005","volume":"121","author":"VL Bonfitto","year":"2003","unstructured":"Bonfitto VL, de Angelo Andrade LA (2003) p53, estrogen and progesterone receptors in diagnostic curettage for endometrial adenocarcinoma and their correlation with morphological data and disease stage at hysterectomy. Sao Paulo Med J 121:163\u2013166","journal-title":"Sao Paulo Med J"},{"key":"9000_CR36","first-page":"1622","volume":"52","author":"MF Kohler","year":"1992","unstructured":"Kohler MF, Berchuck A, Davidoff AM, Humphrey PA, Dodge RK, Iglehart JD, Soper JT, Clarke-Pearson DL, Bast RC Jr, Marks JR (1992) Overexpression and mutation of p53 in endometrial carcinoma. Cancer Res 52:1622\u20131627","journal-title":"Cancer Res"},{"key":"9000_CR37","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1006\/gyno.1996.0214","volume":"62","author":"NW Hamel","year":"1996","unstructured":"Hamel NW, Sebo TJ, Wilson TO, Keeney GL, Roche PC, Suman VJ, Hu TC, Podratz KC (1996) Prognostic value of p53 and proliferation cell nuclear antigen expression in endometrial carcinoma. Gynecol Oncol 62:192\u2013198","journal-title":"Gynecol Oncol"},{"key":"9000_CR38","first-page":"4667","volume":"54","author":"K Ito","year":"1994","unstructured":"Ito K, Watanabe K, Nasim S, Sasano H, Sato S, Yajima A, Silverberg SG, Garrett CT (1994) Prognostic significance of p53 overexpression in endometrial cancer. Cancer Res 54:4667\u20134670","journal-title":"Cancer Res"},{"key":"9000_CR39","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1590\/S1676-24442003000300010","volume":"39","author":"DR Derossi","year":"2003","unstructured":"Derossi DR, Ito K, Couto Filho J, Bacchi CE (2003) Avalia\u00e7\u00e3o da express\u00e3o da prote\u00edna bcl-2 no carcinoma de mama: estudo em pun\u00e7\u00e3o aspirativa por agulha fina; correla\u00e7\u00e3o com grau histol\u00f3gico em esp\u00e9cimes cir\u00fargicos correspondentes. J Bras Patol Med Lab 39:229\u2013235","journal-title":"J Bras Patol Med Lab"}],"container-title":["Pathology &amp; Oncology Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12253-008-9000-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12253-008-9000-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12253-008-9000-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T02:35:44Z","timestamp":1559442944000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12253-008-9000-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,3]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,3]]}},"alternative-id":["9000"],"URL":"https:\/\/doi.org\/10.1007\/s12253-008-9000-9","relation":{},"ISSN":["1219-4956","1532-2807"],"issn-type":[{"value":"1219-4956","type":"print"},{"value":"1532-2807","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,3]]}}}